Company Overview and News

 
Skype co-founder Geoff Prentice turns to funding Southeast Asian microbusinesses

2018-10-17 scmp
Geoff Prentice is now co-founder of financial solutions tech start-up Oriente, which offers purpose-based loans of between US$40 and US$150
JGSMY JGS ATB JGSHF

 
BDO’s Nestor Tan voted “Best CEO”

2018-10-04 business.inquirer.net
BDO Unibank’s long-time chief executive officer (CEO) Nestor Tan was voted “best CEO” in emerging markets (Philippines) in a poll of investors and analysts conducted by New York-based international finance magazine Institutional Investor.
BDOUF BDO JGSMY JGS BDOUY JGSHF

 
Aboitiz bags original proponent status for Bohol airport

2018-09-28 bworldonline
THE Department of Transportation (DoTr) granted original proponent status to Aboitiz InfraCapital, Inc. (AIC) for the operations, maintenance, and future expansion of the New Bohol International Airport in Panglao, the company said on Friday.
FILIY JGSMY ALGGY JGS MPCFF MPCIY MPI ALGGF FDC AGI JGSHF

 
Tan group beefs up infrastructure capital

2018-09-26 bworldonline
LT GROUP, Inc. (LTG) is infusing additional capital to its unit Asia’s Emerging Dragon Corp. (AEDC) to support its foray into infrastructure projects.
JGSMY JGS MPCIY FILIY ALGGY MPI MPCFF ALGGF PNB FDC AGI JGSHF LTG

 
Infracorp plans monorail project linking Eastwood City to MRT-3

2018-09-18 bworldonline
INFRACORP Development, Inc. looks to propose a monorail project connecting the Metro Rail Transit Line 3 (MRT-3) to Eastwood City, in a bid to ease traffic congestion and increase connectivity for commuters in the area.
FILIY JGSMY ALGGY JGS MPCFF MPCIY MPI ALGGF FDC AGI JGSHF

 
NAIA consortium’s P102-B proposal gains ground

2018-09-13 bworldonline
A CONSORTIUM composed of seven of the country’s biggest conglomerates has been given original proponent status (OPS) by the government for its P102-billion proposal to rehabilitate and expand the Ninoy Aquino International Airport (NAIA).
JGSMY JGS MPCIY GMQRY GMRINFRA 532754 FILIY ALGGY MWP MPI MPCFF ALGGF FDC AGI MWIDE JGSHF

 
Villar breaks into Sy-led 10 richest Filipinos list

2018-09-06 bworldonline
HENRY SY, Sr. remains the country’s wealthiest man for the 11th straight year in Forbes Asia’s “Philippines’ 50 Richest” list, which reflected the economy’s overall volatility as many registered shifts in wealth from 2017.
ICT JGSMY GTCAP GTCXY SVTMF NIKL SMCP1 JGS SM ICTEF SECB SMGBF SMIVY SMC ALGGY SBS AGI JGSHF GMA7 SMGBY NIKAY SMC2B SMC2A SMC2D TECH SMC2C SMC2F SYBJF SMC2E ALGGF GNWKY LTG

 
Henry Sy, Sr. still the Philippines’ wealthiest — Forbes Philippines

2018-09-06 bworldonline
SM Group of Companies founder Henry T. Sy, Sr. is still the country’s richest tycoon for 11 consecutive years, according to this year’s Forbes Philippines Rich List.
JGSMY JGS JGSHF

 
Group says no subsidy in Naia rehab offer

2018-09-05 business.inquirer.net
A consortium formed by seven of the country’s biggest conglomerates insisted on Wednesday that it was not seeking any government guarantees, the existence of which could jeopardize its offer to modernize and operate Manila’s Ninoy Aquino International Airport (Naia) for 15 years.
JGSMY JGS MPCIY AEV FILIY ALGGY ABTZY MPI MPCFF ALGGF FDC AGI JGSHF

 
NAIA consortium says proposed terminal fee hike is not a ‘gov’t guarantee’

2018-09-05 bworldonline
THE CONSORTIUM proposing to rehabilitate the Ninoy Aquino International Airport (NAIA) on Wednesday said it is not seeking any government guarantees in its bid to develop and expand the gateway.
FILIY JGSMY ALGGY JGS MPCFF MPCIY MPI ALGGF FDC AGI JGSHF

 
More airport dev’t needed after NAIA closure

2018-08-21 bworldonline
THE Department of Transportation (DoTr) said the disruption to air travel caused by the airport closure caused by the botched landing of a XiamenAir jet last week highlights the need to develop alternative gateways and upgrade systems at existing airports.
JGSMY SMCP1 JGS GMRINFRA GMQRY 532754 SMGBF SMC ALGGY MWP MPCFF MWIDE AGI JGSHF MPCIY SMGBY FILIY SMC2B SMC2A SMC2D SMC2C MPI SMC2F SMC2E ALGGF FDC

 
DoTr chief outlines airport roadmap

2018-08-17 bworldonline
TRANSPORTATION Secretary Arthur P. Tugade outlined the government’s airport roadmap to include multiple airports connecting Bulacan, Cavite, and NCR.
FILIY JGSMY ALGGY JGS MPCFF MPCIY MPI ALGGF FDC AGI JGSHF

 
DENR: Big firms to help revive Boracay wetlands

2018-08-13 newsinfo.inquirer.net
The Department of Environment and Natural Resources (DENR) is allowing the country’s biggest corporations to undertake environmental projects in six of nine wetlands on Boracay Island, amid the government’s ongoing rehabilitation.
EGDCY JGSMY SMCP1 JGS 532219 AEV ENERGYDEV SMGBY SMGBF SMC2B SMC2A SMC SMC2D SMC2C ABTZY SMC2F SMC2E EDC JGSHF

 
JG Summit Holdings, Inc. ADR 2018 Q2 - Results - Earnings Call Slides

2018-08-13 seekingalpha
The following slide deck was published by JG Summit Holdings, Inc. ADR in conjunction with their 2018 Q2 earnings call.
JGSMY JGS JGSHF

 
JG Summit’s second-quarter profit down, revenues up

2018-08-10 bworldonline
JG Summit Holdings, Inc.’s attributable profit dropped by a third in the second quarter of 2018, as the weaker peso, higher fuel prices, as well as rising prices of raw materials for its food, airline, and chemical units tempered the double-digit increase in revenues.
JGSMY RLC JGS URC UVRBY RBLAY JGSHF UVRBF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...